ore holdings inc
(ORXE:OTC Pink - No Information)
Executive Profile*
David L. Urdal Ph.D.Senior Vice President and Director, Dendreon Corp. |
| Age | Total Calculated Compensation | This person is connected to 28 board members in 3 different organizations across 3 different industries. See Board Relationships |
| 62 | $204,750 |
Background*
Dr. David L. Urdal, Ph.D. served as the Chief Scientific Officer of Dendreon Corp. from July 1995 to December 2011 and serves as its Executive Vice President until 2011. Dr. Urdal served as Senior Vice President of Dendreon Corp. since June 2004. Dr. Urdal served President of Dendreon Corp. from January 2001 to December 2003 and served as its Executive Vice President from January 1999 to December 2000. From 1982 to July 1995, Dr. Urdal served various positions with Immunex ...
Corporate Headquarters*One Main StreetCambridge, Massachusetts 02142 United States Phone: 617-649-2001 Fax: -- Board Members Memberships*1995-Present Senior Vice President and Director 2007-Present Director, Chairman of Compensation Committee, Member of Audit Committee and Member of Corporate Governance & Nominating Committee 2008-Present Director
Education*MS University of Washington PhD University of Washington BS University of Washington
Other Affiliations* |
Annual Compensation*There is no Annual Compensation data available.Stock Options*There is no Stock Options data available.Total Compensation*
|
| Recently Viewed | |||
| ORXE:US | $0.14 USD | 0.00 |  |
COMPETITOR COMPENSATION
| Name | Position/ Company | Compensation |
| Vijay B. Samant | Chief Executive Officer, President, Acting Chief Financial Officer and Director Vical Incorporated | $864.8K |
| Christopher Nishan Garabedian | Chief Executive Officer, President and Director Sarepta Therapeutics, Inc. | $490.0K |
| Rajesh C. Shrotriya M.D. | Chairman, Chief Executive Officer, President, Chairman of Placement Committee and Chairman of Product Acquisition Committee Spectrum Pharmaceuticals, Inc. | $2.4M |
| Mark R. Baker J.D. | Chief Executive Officer, Director, Member of Science & Technology Committee and Member of Strategy & External Technology Subcommittee Progenics Pharmaceuticals, Inc. | $672.8K |
| Joseph S. Zakrzewski | Executive Chairman and Chief Executive Officer Amarin Corporation plc | $550.0K | Compensation as of Fiscal Year 2012. |
Post a JobJobs
- Orlando, FL | Consult SoftPosted: May 22
- New York, NY |Posted: May 17
- San Francisco, CA | YelpPosted: May 02
- San Francisco, CA | YelpPosted: May 02
Sponsored Financial Commentaries
Sponsored Links
To contact ORE HOLDINGS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.
Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.
